QRP Research Hexarelin 5mg
Hexarelin is a synthetic hexapeptide belonging to the Growth Hormone-Releasing Peptide (GHRP) family and has been extensively investigated as a growth hormone secretagogue in experimental endocrine and neuroendocrine research.
Hexarelin interacts with the growth hormone secretagogue receptor (GHS-R), a G-protein-coupled receptor involved in the regulation of growth hormone signalling. Experimental research has demonstrated that Hexarelin can influence GH secretion through pituitary and hypothalamic pathways, making it a useful research compound for investigating growth hormone regulation and growth hormone secretagogue receptor activity.
In addition to its endocrine research applications, Hexarelin has attracted scientific interest because experimental studies have identified GHRP-associated binding sites in peripheral tissues, including cardiovascular tissue. Research has also investigated GH-independent signalling mechanisms associated with Hexarelin and related GHRPs.
QRP Research Hexarelin 5mg is supplied as a lyophilised research peptide intended exclusively for controlled laboratory, analytical and scientific investigation.
Key Research Areas
Hexarelin has been investigated experimentally in relation to:
Growth hormone secretagogue receptor (GHS-R) signalling
Growth hormone secretion and regulation
Pituitary and hypothalamic signalling
Ghrelin-receptor pathways
GHRH and GHRP signalling interactions
Endocrine and neuroendocrine mechanisms
Growth hormone regulatory pathways
Peptide-receptor interactions
Peripheral GHRP-associated receptor research
Cardiovascular and myocardial signalling pathways
Research has identified CD36 as a molecular target associated with certain cardiovascular actions of growth hormone-releasing peptides, providing an additional area of experimental interest distinct from classical GHS-R-mediated endocrine signalling.
Research findings involving Hexarelin should not be interpreted as evidence of established therapeutic, performance-enhancing or other clinical effects.
Product Specification
Compound: Hexarelin
Compound Type: Synthetic hexapeptide / Growth Hormone Secretagogue
Peptide Family: Growth Hormone-Releasing Peptides (GHRPs)
Primary Research Target: Growth Hormone Secretagogue Receptor (GHS-R)
Form: Lyophilised peptide
Quantity: 5mg per vial
Brand: QRP Research
Application: Laboratory and scientific research
Why QRP Research?
QRP Research supplies specialist research materials with an emphasis on quality, consistency and traceability. Products are securely packaged and clearly identified for their intended laboratory application.
Storage
Store in a cool, dry and dark environment, protected from excessive heat, direct light and moisture. Appropriate laboratory storage procedures should be followed to maintain material integrity.
Research Use Notice
FOR RESEARCH USE ONLY.
This product is supplied exclusively for laboratory, analytical and scientific research.
NOT for human consumption.
NOT for animal consumption.
NOT a medicine, food supplement or cosmetic product.
NOT intended to diagnose, treat, cure or prevent any disease.
No human dosing or administration instructions are provided.
Intended to be handled only by appropriately qualified researchers or laboratory professionals.
QRP Research Hexarelin 5mg is supplied strictly as a research material for non-clinical laboratory investigation.